Ophthalmology Search
Ophthalmology Ophthalmology
conjunctivitis%20-%20viral
CONJUNCTIVITIS - VIRAL
Viral conjunctivitis is the inflammation of the conjunctiva of viral etiology.
Signs and symptoms include unilateral or bilateral eye redness, foreign body sensation and follicular conjunctival reaction.
It may be caused by adenovirus, herpes simplex or molluscum contagiosum.

Conjunctivitis%20-%20viral Signs and Symptoms

Introduction

  • A highly contagious acute conjunctival infection usually caused by adenovirus 
  • May be a part of a viral prodrome or is the only symptom of a viral illness 

Definition

  • Inflammation of the conjunctiva of viral etiology 

Signs and Symptoms

  • Symptoms become worse for the first 3-5 days then gradually resolve in 2-3 weeks
  • Common upper respiratory coinfection
  • Mild to moderate eye redness & pruritus
  • Watery eye discharge
  • Rare bilateral eye involvement
  • Foreign body sensation
  • Follicular conjunctival reaction
  • Common lymphadenopathy
Editor's Recommendations
Most Read Articles
A Guide on Primary Immunodeficiency Disease and Allergies
05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.
New asthma guide: What doctors should know
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
Severe/critical COVID-19 may up perinatal risk
Roshini Claire Anthony, 6 days ago

Critical or severe COVID-19 disease could raise the risk of negative perinatal outcomes in pregnant women, according to an observational study from the US.
Dexamethasone lowers mortality, ventilation use in ARDS
Stephen Padilla, 22 Feb 2021
Treatment with intravenous (IV) dexamethasone for 10 days significantly reduces duration of mechanical ventilation at 28 days and 60-day mortality in patients with established moderate-to-severe acute respiratory disease syndrome (ARDS) compared with no dexamethasone, results of the DEXA-ARDS trial have shown.